ProfileGDS5678 / 1438845_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 25% 25% 25% 25% 24% 24% 24% 25% 24% 25% 25% 25% 25% 29% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.6047425
GSM967853U87-EV human glioblastoma xenograft - Control 22.5787825
GSM967854U87-EV human glioblastoma xenograft - Control 32.578925
GSM967855U87-EV human glioblastoma xenograft - Control 42.5253125
GSM967856U87-EV human glioblastoma xenograft - Control 52.5191524
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.6303324
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.5944124
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.5531125
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.5439324
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.5670225
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.5644525
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.5475925
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.56925
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6620429